Page last updated: 2024-11-04

sevoflurane and Lacrimal Duct Obstruction

sevoflurane has been researched along with Lacrimal Duct Obstruction in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaur, M1
Yadav, A1

Other Studies

1 other study available for sevoflurane and Lacrimal Duct Obstruction

ArticleYear
Anaesthetic implications of Rubinstein-Taybi syndrome.
    Journal of clinical anesthesia, 2019, Volume: 56

    Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Child, Preschool; Dacryocystorhinostomy; Humans; La

2019